Xiaogang Wang

Xiaogang Wang

Auto-generated profile, based on publicly available information

Xiaogang Wang

Department of Laboratory Medicine, School of Medicine, The Second Affiliated Hospital South China University of Technology (Guangzhou First People's Hospital), Guangzhou 510180, China

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2024 in Lab on a Chip
Verified
Journal Article
Closed access
PDF file
XWXiaogang Wang
Xiaogang Wang
THTao He
Tao He
ZCZihe Chen
Zihe Chen
JCJueming Chen
Jueming Chen
YLYanzhang Luo
Yanzhang Luo
DLDayu Liu
Dayu Liu
The suboptimal prognosis associated with drug therapy for renal cancer can be attributed to the presence of stem-cell-like renal cancer cells. However, the limited number of these cells prevents conventional drug screening assays from effectively assessing the response of renal cancer stem cells to anti-cancer agents. To address this issue, the present study employed microfluidic single-cell culture arrays to expand renal cancer stem cells by exploiting the anti-apoptosis and self-renewal properties of tumor stem cells. A microfluidic chip with 18 000 hydrophilic microwells was designed and fabricated to establish the single-cell culture array. Over a 7 day culture, the large-scale single-cell culture yielded a limited quantity of single-cell-derived tumorspheres. The sphere formation rates for Caki-1, 786-O, and ACHN cells were determined to be 8.74 ± 0.53%, 12.02 ± 1.43%, and 4.98 ± 1.68%, respectively. The expanded cells exhibited stemness characteristics, as indicated by immunofluorescence, flow cytometry, serial passaging, and in vitro differentiation assays. Additionally, the comparative transcriptomic analysis showed significant differences in the gene expression patterns of the expanded cells compared to the differentiated renal cancer cells. The drug testing indicated that renal cancer stem cells exhibited reduced sensitivity towards the tyrosine kinase inhibitors sorafenib and sunitinib, compared to differentiated renal cancer cells. This reduced sensitivity can be attributed to the elevated expression levels of tyrosine kinase in renal cancer stem cells. This present study provides evidence that the utilization of microfluidic single-cell culture arrays for selective cell expansion can facilitate drug testing of renal cancer stem cells.

12 September 2017 in RSC Advances
Verified
Journal Article
Open access
PDF file
XWXiaogang Wang
Xiaogang Wang
YJYiying Jin
Yiying Jin
WWWei Wang
Wei Wang
NYNa Yu
Na Yu
XXXue Xiao
Xue Xiao
XXianCheng Li
XianCheng Li
MicroRNAs (miR) play important roles in cancer invasion. In this study, we investigated the role of miR-21 in the invasion of renal cell carcinoma. The invasive abilities of renal carcinoma cell lines (786-O, Caki-1, A498), one normal epithelial kidney cell line (HK-2) and primary renal carcinoma cells were assessed in a microfluidic model. The expression of miR-21 was examined by quantitative real time PCR (qRT-PCR). We found that HK-2 cells with low miR-21 expression showed low invasive ability while renal carcinoma cell lines with high miR-21 expression showed high invasive ability. Primary renal cancer cells showed higher invasive ability than HK-2 cells, and this was consistent with the level of miR-21 expression. miR-21 knockdown reduced both renal carcinoma cell line and primary cancer cell invasion. Overall, this study shows that miR-21 promotes renal cancer cell invasion in both cell lines and primary cancer cells and suggests that miR-21 might be a new target in renal cancer therapy. In addition, we demonstrate that a microfluidic device provides a useful in vitro platform to study cancer cell invasion.

23 January 2026 in Lab on a Chip
Verified
Journal Article
Closed access
PDF file
JCJueming Chen
Jueming Chen
XWXiaogang Wang
Xiaogang Wang
WYWeijie Ye
Weijie Ye
HKHui Kang
Hui Kang
SXSiyan Xiao
Siyan Xiao
DLDayu Liu
Dayu Liu
This study demonstrates the versatility of microfluidic single-cell culture methodologies across diverse types of tumors, facilitating the selective expansion of tumor stem cells and the generation of single-cell-derived tumor organoids.

24 November 2025 in Lab on a Chip
Verified
Journal Article
Closed access
PDF file
HKHui Kang
Hui Kang
XWXiaogang Wang
Xiaogang Wang
WYWeijie Ye
Weijie Ye
YLYanzhang Luo
Yanzhang Luo
JCJueming Chen
Jueming Chen
DLDayu Liu
Dayu Liu
Tumorspheres in open-surface microwell arrays were repeatedly exposed to an anticancer drug combination to investigate the biological responses and dormancy characteristics of colorectal cancer cells within.